NANOMETRICS INCORPORATED | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||
(In thousands) | |||||||||
(Unaudited) | |||||||||
Six Months Ended | |||||||||
June 25,
2016 |
June 27,
2015 | ||||||||
Cash flows from operating activities: | |||||||||
Net income | $ | 9,498 | $ | 3,900 | |||||
Reconciliation of net income to net cash from operating activities: | |||||||||
Depreciation and amortization | 4,305 | 4,555 | |||||||
Stock-based compensation | 3,432 | 2,982 | |||||||
Loss on disposal of fixed assets | 128 | 501 | |||||||
Inventory write down | 1,046 | 1,298 | |||||||
Deferred income taxes | (30 | ) | 136 | ||||||
Changes in fair value of contingent consideration | 95 | 93 | |||||||
Changes in assets and liabilities: | |||||||||
Accounts receivable | (14,277 | ) | (19,030 | ) | |||||
Inventories | 6,457 | (8,442 | ) | ||||||
Inventories-delivered systems | (6,737 | ) | 339 | ||||||
Prepaid expenses and other | (151 | ) | 2,735 | ||||||
Accounts payable, accrued and other liabilities | (1,511 | ) | 4,283 | ||||||
Deferred revenue | 12,080 | (579 | ) | ||||||
Income taxes payable | (1,115 | ) | 72 | ||||||
Net cash provided by (used in) operating activities | 13,220 | (7,157 | ) | ||||||
Cash flows from investing activities: | |||||||||
Sales of marketable securities | - | 2,383 | |||||||
Maturities of marketable securities | 21,816 | 15,836 | |||||||
Purchases of marketable securities | (12,880 | ) | (17,561 | ) | |||||
Purchase of property, plant and equipment | (2,528 | ) | (1,043 | ) | |||||
Net cash provided by (used in) investing activities | 6,408 | (385 | ) | ||||||
Cash flows from financing activities: | |||||||||
Payments to Zygo Corporation related to acquisition | (315 | ) | (417 | ) | |||||
Proceeds from sale of shares under employee stock option and purchase plans | 3,466 | 2,500 | |||||||
Taxes paid on net issuance of stock awards | (1,288 | ) | (1,015 | ) | |||||
Repurchases of common stock | - | (1,721 | ) | ||||||
Net cash provided by (used in) financing activities | 1,863 | (653 | ) | ||||||
Effect of exchange rate changes on cash and cash equivalents | 387 | (60 | ) | ||||||
Net increase (decrease) in cash and cash equivalents | 21,878 | (8,255 | ) | ||||||
Cash and cash equivalents, beginning of period | 38,154 | 34,676 | |||||||
Cash and cash equivalents, end of period | $ | 60,032 | $ | 26,421 | |||||